APA (7th ed.) Citation

R, W., WFC, R., D, v. d. H., DWT, C., W, S., J, K., . . . GR, B. (2021). Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: The phase 3, randomised controlled FINCH 3 trial. Annals of the rheumatic diseases, 80(6), 727. https://doi.org/10.1136/annrheumdis-2020-219213

Chicago Style (17th ed.) Citation

R, Westhovens, et al. "Filgotinib in Combination with Methotrexate or as Monotherapy Versus Methotrexate Monotherapy in Patients with Active Rheumatoid Arthritis and Limited or No Prior Exposure to Methotrexate: The Phase 3, Randomised Controlled FINCH 3 Trial." Annals of the Rheumatic Diseases 80, no. 6 (2021): 727. https://doi.org/10.1136/annrheumdis-2020-219213.

MLA (9th ed.) Citation

R, Westhovens, et al. "Filgotinib in Combination with Methotrexate or as Monotherapy Versus Methotrexate Monotherapy in Patients with Active Rheumatoid Arthritis and Limited or No Prior Exposure to Methotrexate: The Phase 3, Randomised Controlled FINCH 3 Trial." Annals of the Rheumatic Diseases, vol. 80, no. 6, 2021, p. 727, https://doi.org/10.1136/annrheumdis-2020-219213.